Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Double-blind, placebo-controlled, cross-over design study examining the effects of a norepinephrine alpha1 receptor antagonist (prazosin) on stress reactivity in a laboratory stressor task.
Epistemonikos ID: 9ef6807e227e0871ba5fcd0012eb8d50416e866c
First added on: May 20, 2024